These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26165041)

  • 21. The clinical biology of breast cancer.
    Carlson RW; Stockdale FE
    Annu Rev Med; 1988; 39():453-64. PubMed ID: 2835930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic immunohistochemistry of breast epithelial lesions].
    Balaton AJ; Guinebretière JM; Penault-Llorca F
    Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cell receptors and proliferation markers in breast cancer].
    Czerwenka KF; Schön HJ; Zeillinger R; Kubista E; Spona J
    Gynakol Rundsch; 1989; 29 Suppl 2():400-1. PubMed ID: 2558992
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of alpha-difluoromethylornithine on markers of proliferation, invasion, and apoptosis in breast cancer.
    Izbicka E; Streeper RT; Yeh IT; Pressley O; Grant M; Andrews JV; Kuhn J; O'Shaughnessy J
    Anticancer Res; 2010 Jun; 30(6):2263-9. PubMed ID: 20651378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases.
    Esposito NN; Dabbs DJ; Bhargava R
    Am J Clin Pathol; 2009 Feb; 131(2):228-42. PubMed ID: 19141383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is breast tumor progression really linear?
    Polyak K
    Clin Cancer Res; 2008 Jan; 14(2):339-41. PubMed ID: 18223205
    [No Abstract]   [Full Text] [Related]  

  • 27. [Radiotherapy of breast carcinoma. 2005 version].
    Organgruppe "Mammakarzinom" der DEGRO
    Strahlenther Onkol; 2006 Feb; 182 Suppl 1():4-28. PubMed ID: 16613299
    [No Abstract]   [Full Text] [Related]  

  • 28. Significance of HER2 protein examination in ductal carcinoma in situ.
    Horimoto Y; Tokuda E; Arakawa A; Kosaka T; Saito M; Kasumi F
    J Surg Res; 2011 May; 167(2):e205-10. PubMed ID: 20018297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Squamous cell carcinoma in situ of the breast: a light microscopic and immunohistochemical study of a previously undescribed lesion.
    Hayes MM; Peterse JL; Yavuz E; Vischer GH; Eusebi V
    Am J Surg Pathol; 2007 Sep; 31(9):1414-9. PubMed ID: 17721198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast.
    Boland GP; McKeown A; Chan KC; Prasad R; Knox WF; Bundred NJ
    Br J Cancer; 2003 Jul; 89(2):277-83. PubMed ID: 12865917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretory breast carcinoma with extensive intraductal component: case report.
    Celik A; Kutun S; Pak I; Seki A; Cetin A
    Ultrastruct Pathol; 2004; 28(5-6):361-3. PubMed ID: 15764584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collagen, type XI, alpha 1: an accurate marker for differential diagnosis of breast carcinoma invasiveness in core needle biopsies.
    Freire J; Domínguez-Hormaetxe S; Pereda S; De Juan A; Vega A; Simón L; Gómez-Román J
    Pathol Res Pract; 2014 Dec; 210(12):879-84. PubMed ID: 25175819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encapsulated papillary carcinoma of the breast: a study of invasion associated markers.
    Rakha EA; Tun M; Junainah E; Ellis IO; Green A
    J Clin Pathol; 2012 Aug; 65(8):710-4. PubMed ID: 22554960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
    Remmele W; Schicketanz KH
    Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
    [No Abstract]   [Full Text] [Related]  

  • 35. Ductal carcinoma in situ and microinvasive disease. American College of Radiology. ACR Appropriateness Criteria.
    Rabinovitch RA; Solin LJ; Shank BM; Haffty BG; Halberg FE; Martinez AA; McCormick B; McNeese MD; Mendenhall NP; Mitchell SE; Taylor ME; Singletary SE; Leibel S
    Radiology; 2000 Jun; 215 Suppl():1137-52. PubMed ID: 11037538
    [No Abstract]   [Full Text] [Related]  

  • 36. Breast cancer. Dare to do less.
    Marshall E
    Science; 2014 Mar; 343(6178):1454-6. PubMed ID: 24675949
    [No Abstract]   [Full Text] [Related]  

  • 37. [Role of prognostic factors in evaluation of survival in breast cancer].
    Popârlan T; Muscă S
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):147-51. PubMed ID: 20509292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Japan Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer.
    Komoike Y; Inokuchi M; Itoh T; Kitamura K; Kutomi G; Sakai T; Jinno H; Wada N; Ohsumi S; Mukai H;
    Breast Cancer; 2015 Jan; 22(1):37-48. PubMed ID: 25091115
    [No Abstract]   [Full Text] [Related]  

  • 39. [Special techniques for diagnosis of breast changes].
    Olszewski WP
    Pol J Pathol; 2011 Dec; 62(4 Suppl 4):s26-7. PubMed ID: 22693729
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of breast lesions with proton MR spectroscopy.
    Yeh ED
    AJR Am J Roentgenol; 2003 Nov; 181(5):1273-4. PubMed ID: 14573419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.